The New York TimesApr 18, 2:40 AM

Trump Expected to Loosen Restrictions on Psychedelic Drugs

An upcoming executive order is intended to accelerate research into the compounds’ efficacy in treating PTSD, depression and other mental health problems, officials said.

The GuardianApr 18, 3:03 PM

Trump announces reforms to accelerate access to psychedelic drug treatments

President signed executive order directing FDA to expedite review of psychedelic drugs including ibogaine Donald Trump on Saturday announced reforms intended to speed up access to medical research and treatment based on psychedelic drugs. The president signed an executive order directing the federal Food and Drug Administration (FDA) to expedite review of drugs such as ibogaine, a drug that US military veteran groups have said can help treat post-traumatic stress disorder . Continue reading...

Al JazeeraApr 18, 5:46 PM

Trump joined by Joe Rogan as he signs order to speed up psychedelic review

Order calls on federal government to relax restrictions on psychedelics, including ibogaine, for potential treatments.

NPRApr 18, 6:56 PM

Trump signs order fast tracking review of psychedelics for mental health disorders

President endorses psilocybin and ibogaine: "Can I have some, please?"

CNBCApr 20, 6:05 PM

How Trump's psychedelics executive order could unlock stalled cannabis reform

The White House psychedelics executive order accelerates research, clinical trials and "Right to Try" access for drugs like psilocybin, MDMA and ibogaine.

The New York TimesApr 18, 2:40 AM

Trump Expected to Loosen Restrictions on Psychedelic Drugs

An upcoming executive order is intended to accelerate research into the compounds’ efficacy in treating PTSD, depression and other mental health problems, officials said.

The GuardianApr 18, 3:03 PM

Trump announces reforms to accelerate access to psychedelic drug treatments

President signed executive order directing FDA to expedite review of psychedelic drugs including ibogaine Donald Trump on Saturday announced reforms intended to speed up access to medical research and treatment based on psychedelic drugs. The president signed an executive order directing the federal Food and Drug Administration (FDA) to expedite review of drugs such as ibogaine, a drug that US military veteran groups have said can help treat post-traumatic stress disorder . Continue reading...

Al JazeeraApr 18, 5:46 PM

Trump joined by Joe Rogan as he signs order to speed up psychedelic review

Order calls on federal government to relax restrictions on psychedelics, including ibogaine, for potential treatments.

NPRApr 18, 6:56 PM

Trump signs order fast tracking review of psychedelics for mental health disorders

President endorses psilocybin and ibogaine: "Can I have some, please?"

CNBCApr 20, 6:05 PM

How Trump's psychedelics executive order could unlock stalled cannabis reform

The White House psychedelics executive order accelerates research, clinical trials and "Right to Try" access for drugs like psilocybin, MDMA and ibogaine.